Literature DB >> 13880807

Studies on the biologic relationship of endotoxin and other toxic proteins. I. Comparison of the properties of snake venom and endotoxin.

R M CONDIE, E V STAAB, R A GOOD.   

Abstract

1. Agkistrodon piscivorus venom and E. coli endotoxin were shown to be immunologically distinct, and to differ in certain biologic properties: effects on immune response, body temperature, and circulating leukocyte count, and capacity to prepare for and provoke the local and generalized Shwartzman reaction. 2. Neither a single prior injection of venom nor the existence of hyperimmunity to lethal doses of venom protected rabbits against the local and generalized Shwartzman reaction. 3. Serial intravenous injections of sublethal doses of venom produced enhanced susceptibility to venom rather than refractoriness. 4. Preparation for both the local and generalized Shwartzman reaction with endotoxin appeared to enhance susceptibility of rabbits to challenge with venom. 5. Tolerance to bacterial pyrogens established by repeated injections of endotoxin is paralleled by increased resistance to snake venom given at least 1 week later, in mice and rabbits. 6. Zymosan failed to enhance susceptibility of rabbits to venom, but thorotrast increased the number of late deaths from venom. 7. Exposure of venom to ferrous sulfate interferes with its toxicity.

Entities:  

Keywords:  ALLERGY/experimental; TOXINS AND ANTITOXINS/pharmacology; VENOMS/toxicology

Mesh:

Substances:

Year:  1962        PMID: 13880807      PMCID: PMC2137499          DOI: 10.1084/jem.115.3.563

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Bacterial pyrogens.

Authors:  I L BENNETT; L E CLUFF
Journal:  Pharmacol Rev       Date:  1957-12       Impact factor: 25.468

2.  A quantitative study of a technique of double diffusion in agar.

Authors:  J R PREER
Journal:  J Immunol       Date:  1956-07       Impact factor: 5.422

3.  Rapidly induced changes in the level of non-specific immunity in laboratory animals.

Authors:  D ROWLEY
Journal:  Br J Exp Pathol       Date:  1956-06

4.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

5.  The physiological disturbances produced by endotoxins.

Authors:  L THOMAS
Journal:  Annu Rev Physiol       Date:  1954       Impact factor: 19.318

6.  Endotoxins.

Authors:  W BURROWS
Journal:  Annu Rev Microbiol       Date:  1951       Impact factor: 15.500

7.  The effect of bacterial constituents on the resistance of mice to heterologous infection and on the activity of their reticulo-endothelial system.

Authors:  D BOEHME; R J DUBOS
Journal:  J Exp Med       Date:  1958-04-01       Impact factor: 14.307

8.  The properdin system and immunity. III. The zymosan assay of properdin.

Authors:  L PILLEMER; L BLUM; I H LEPOW; L WURZ; E W TODD
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

9.  Reversible changes in the susceptibility of mice to bacterial infections. I. Changes brought about by injection of pertussis vaccine or of bacterial endotoxins.

Authors:  R J DUBOS; R W SCHAEDLER
Journal:  J Exp Med       Date:  1956-07-01       Impact factor: 14.307

10.  Studies on the generalized Shwartzman reaction. II. The production of bilateral cortical necrosis of the kidneys by a single injection of bacterial toxin in rabbits previously treated with thorotrast or trypan blue.

Authors:  R A GOOD; L THOMAS
Journal:  J Exp Med       Date:  1952-12       Impact factor: 14.307

View more
  2 in total

Review 1.  Molecular aspects of endotoxic reactions.

Authors:  A Nowotny
Journal:  Bacteriol Rev       Date:  1969-03

2.  Studies on the biologic relationship of endotoxin and other toxic proteins. II. Enhancement of susceptibility to snake venom by endotoxin.

Authors:  E V STAAB; R M CONDIE; R A GOOD
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.